VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 70 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3 | -99.9% | 650 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | +200.0% | 650 | +155.9% | 0.00% | – |
| Q2 2022 | $1,000 | -97.8% | 254 | -94.8% | 0.00% | -100.0% |
| Q1 2020 | $45,000 | -45.8% | 4,865 | -18.0% | 0.00% | 0.0% |
| Q4 2019 | $83,000 | -19.4% | 5,930 | -1.4% | 0.00% | 0.0% |
| Q3 2019 | $103,000 | -38.3% | 6,012 | -2.2% | 0.00% | -50.0% |
| Q2 2019 | $167,000 | – | 6,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $120,921,000 | 54.00% |
| Trustees of Princeton University | 203,632 | $3,853,000 | 5.43% |
| GREAT POINT PARTNERS LLC | 1,400,000 | $26,488,000 | 4.13% |
| Casdin Capital, LLC | 1,135,000 | $21,474,000 | 2.61% |
| ARMISTICE CAPITAL, LLC | 1,724,000 | $32,618,000 | 1.96% |
| BB BIOTECH AG | 2,822,641 | $53,404,000 | 1.41% |
| HARBOURVEST PARTNERS LLC | 72,726 | $1,376,000 | 1.24% |
| Aevitas Wealth Management, Inc. | 62,323 | $1,179,000 | 1.07% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,001,870 | $18,955,000 | 0.88% |
| Patriot Financial Group Insurance Agency, LLC | 60,586 | $1,146,000 | 0.68% |